{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T03:26:14Z","timestamp":1769570774698,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10840-020-00870-3","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T03:57:31Z","timestamp":1600487851000},"page":"603-616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3138-8354","authenticated-orcid":false,"given":"Gustavo","family":"Lima da Silva","sequence":"first","affiliation":[]},{"given":"Afonso","family":"Nunes-Ferreira","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Cortez-Dias","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"de Sousa","sequence":"additional","affiliation":[]},{"given":"Fausto","family":"J. Pinto","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Caldeira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,9,19]]},"reference":[{"key":"870_CR1","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Bloma N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793\u2013867.","journal-title":"Eur Heart J"},{"key":"870_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa013474","volume":"346","author":"AJ Moss","year":"2003","unstructured":"Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2003;346:877\u201383.","journal-title":"N Engl J Med"},{"key":"870_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter\u2013defibrillator for congestive heart failure. N Engl J Med. 2005;352:225\u201337.","journal-title":"N Engl J Med"},{"key":"870_CR4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa071098","volume":"359","author":"JE Poole","year":"2008","unstructured":"Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009\u201317.","journal-title":"N Engl J Med"},{"key":"870_CR5","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1161\/01.CIR.0000150390.04704.B7","volume":"110","author":"AJ Moss","year":"2004","unstructured":"Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110:3760\u20135.","journal-title":"Circulation"},{"key":"870_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1099-5129(03)00078-3","volume":"5","author":"HCM Kamphuis","year":"2003","unstructured":"Kamphuis HCM, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace. 2003;5:381\u20139.","journal-title":"Europace"},{"key":"870_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1067\/mjh.2002.124049","volume":"144","author":"J Irvine","year":"2002","unstructured":"Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J. 2002;144:282\u20139.","journal-title":"Am Heart J"},{"key":"870_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1161\/hc0502.103330","volume":"105","author":"EB Schron","year":"2002","unstructured":"Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105:589\u201394.","journal-title":"Circulation"},{"key":"870_CR9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/europace\/euz132","volume":"21","author":"EM Cronin","year":"2019","unstructured":"Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, et al. 2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace. 2019;21:1143\u20134.","journal-title":"Europace"},{"key":"870_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jacep.2017.12.008","volume":"4","author":"J Romero","year":"2018","unstructured":"Romero J, Di Biase L, Diaz JC, Quispe R, Du X, Briceno D, et al. Early versus late referral for catheter ablation of ventricular tachycardia in patients with structural heart disease: a systematic review and meta-analysis of clinical outcomes. JACC Clin Electrophysiol. 2018;4:374\u201382.","journal-title":"JACC Clin Electrophysiol"},{"key":"870_CR11","doi-asserted-by":"crossref","first-page":"e003841","DOI":"10.1161\/CIRCEP.115.003841","volume":"9","author":"CM Tschabrunn Bardy","year":"2016","unstructured":"Tschabrunn Bardy CM, Roujol S, Dorman NC, Nezafat R, Josephson ME, Anter E. High-resolution mapping of ventricular scar: comparison between single and multielectrode catheters. Circ Arrhythmia Electrophysiol. 2016;9:e003841.","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"870_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/CIRCULATIONAHA.116.021955","volume":"134","author":"E Anter","year":"2016","unstructured":"Anter E, Tschabrunn CM, Buxton AE, Josephson ME. High-resolution mapping of postinfarction reentrant ventricular tachycardia: electrophysiological characterization of the circuit. Circulation. 2016;134:314\u201327.","journal-title":"Circulation"},{"key":"870_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.hrthm.2016.11.018","volume":"14","author":"K Viswanathan","year":"2017","unstructured":"Viswanathan K, Mantziari L, Butcher C, Hodkinson E, Lim E, Khan H, et al. Evaluation of a novel high-resolution mapping system for catheter ablation of ventricular arrhythmias. Hear Rhythm. 2017;14:176\u201383.","journal-title":"Hear Rhythm"},{"key":"870_CR14","doi-asserted-by":"crossref","first-page":"e004072","DOI":"10.1161\/CIRCEP.116.004072","volume":"9","author":"V Luther","year":"2016","unstructured":"Luther V, Linton NWF, Jamil-Copley S, Koa-Wing M, Lim PB, Qureshi N, et al. A prospective study of ripple mapping the post-infarct ventricular scar to guide substrate ablation for ventricular tachycardia. Circ Arrhythmia Electrophysiol. 2016;9:e004072.","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"870_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jacep.2017.12.005","volume":"4","author":"A Porta-S\u00e1nchez","year":"2018","unstructured":"Porta-S\u00e1nchez A, Jackson N, Lukac P, Kristiansen SB, Nielsen JM, Gizurarson S, et al. Multicenter study of ischemic ventricular tachycardia ablation with decrement-evoked potential (DEEP) mapping with extra stimulus. JACC Clin Electrophysiol. 2018;4:307\u201315.","journal-title":"JACC Clin Electrophysiol"},{"key":"870_CR16","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.119.042423","volume":"140","author":"Z Aziz","year":"2019","unstructured":"Aziz Z, Shatz D, Raiman M, Upadhyay GA, Beaser AD, Besser SA, et al. Targeted ablation of ventricular tachycardia guided by wavefront discontinuities during sinus rhythm: a new functional substrate mapping strategy. Circulation. 2019;140:1383\u201397.","journal-title":"Circulation"},{"key":"870_CR17","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"870_CR18","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008\u201312.","journal-title":"JAMA"},{"key":"870_CR19","doi-asserted-by":"crossref","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencow NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. l4898.","DOI":"10.1136\/bmj.l4898"},{"key":"870_CR20","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D Atkins","year":"2004","unstructured":"Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.","journal-title":"BMJ"},{"key":"870_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401\u20136.","journal-title":"J Clin Epidemiol"},{"key":"870_CR22","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1056\/NEJMoa065457","volume":"375","author":"VY Reddy","year":"2007","unstructured":"Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;375:2657\u201365.","journal-title":"N Engl J Med"},{"key":"870_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","volume":"375","author":"KH Kuck","year":"2010","unstructured":"Kuck KH, Schaumann A, Willems S, Willems S, Ventura R, Delacr\u00e9taz E, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375:31\u201340.","journal-title":"Lancet"},{"key":"870_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jce.12567","volume":"26","author":"SM Al-Khatib","year":"2015","unstructured":"Al-Khatib SM, Daubert JP, Anstrom KJ, Daoud EG, Gonzalez M, Saba S, et al. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. J Cardiovasc Electrophysiol. 2015;26:151\u20137.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"870_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1513614","volume":"375","author":"JL Sapp","year":"2016","unstructured":"Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375:111\u201321.","journal-title":"N Engl J Med"},{"key":"870_CR26","doi-asserted-by":"crossref","first-page":"e004422","DOI":"10.1161\/CIRCEP.116.004422","volume":"3","author":"KH Kuck","year":"2017","unstructured":"Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol. 2017;3:e004422.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"870_CR27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","volume":"141","author":"S Willems","year":"2020","unstructured":"Willems S, Tilz RR, Steven D, K\u00e4\u00e4b S, Wegscheider K, Gell\u00e9r L, et al. Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial. Circulation. 2020;141:1057\u20136.","journal-title":"Circulation"},{"key":"870_CR28","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/j.hrthm.2019.04.024","volume":"17","author":"BK Martinez","year":"2020","unstructured":"Martinez BK, Baker WL, Konopka A, Giannelli D, Coleman CI, Kluger J, et al. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Hear Rhythm. 2020;17:e206\u201319.","journal-title":"Hear Rhythm"},{"key":"870_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10840-018-0376-5","volume":"53","author":"V Atti","year":"2018","unstructured":"Atti V, Vuddanda V, Turagam MK, Vemula P, Shah Z, Nagam H, et al. Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials. J Interv Card Electrophysiol. 2018;53:207\u201315.","journal-title":"J Interv Card Electrophysiol"},{"key":"870_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijcard.2018.03.127","volume":"267","author":"W Maskoun","year":"2018","unstructured":"Maskoun W, Saad M, Abualsuod A, Nairooz R, Miller JM. Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: a systematic review and meta-analysis of randomized clinical trials. Int J Cardiol. 2018;267:107\u201313.","journal-title":"Int J Cardiol"},{"key":"870_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.295.2.165","volume":"295","author":"SJ Connolly","year":"2006","unstructured":"Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of \u03b2-blockers, amiodarone plus \u03b2-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators - the OPTIC study: a randomized trial. J Am Med Assoc. 2006;295:165\u201371.","journal-title":"J Am Med Assoc"},{"key":"870_CR32","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJM199906173402402","volume":"340","author":"A Pacifico","year":"1999","unstructured":"Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med. 1999;340:1855\u201362.","journal-title":"N Engl J Med"},{"key":"870_CR33","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.hrthm.2016.04.001","volume":"13","author":"SD Pokorney","year":"2016","unstructured":"Pokorney SD, Friedman DJ, Calkins H, Sapp J, Stevenson WG, Al-Khatib S, et al. Catheter ablation of ventricular tachycardia: lessons learned from past clinical trials and implications for future clinical trials. Heart Rhythm. 2016;13:1748\u201354.","journal-title":"Heart Rhythm"},{"key":"870_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1161\/CIRCHEARTFAILURE.110.957480","volume":"4","author":"DS Lee","year":"2011","unstructured":"Lee DS, Gona P, Albano I, Larson MG, Benjamin EJ, Levy D, et al. A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ Heart Fail. 2011;4:36\u201343.","journal-title":"Circ Heart Fail"},{"key":"870_CR35","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1001\/jamacardio.2019.3593","volume":"4","author":"N Conrad","year":"2019","unstructured":"Conrad N, Judge A, Canoy D, Tran J, Pinho-Gomes AC, Millett E, et al. Temporal trends and patterns in mortality after incident heart failure: a longitudinal analysis of 86 000 individuals. JAMA Cardiol. 2019;4:1102\u201311.","journal-title":"JAMA Cardiol"},{"key":"870_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/jce.13419","volume":"29","author":"LJ Gula","year":"2018","unstructured":"Gula LJ, Doucette S, Leong-Sit P, Tang A, Parkash R, Sarrazin JF, et al. Quality of life with ablation or medical therapy for ventricular arrhythmias: a substudy of VANISH. J Cardiovasc Electrophysiol. 2018;29:421\u201334.","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-020-00870-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-020-00870-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-020-00870-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T06:22:21Z","timestamp":1668838941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-020-00870-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,19]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1007\/s10840-020-00870-3","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,19]]},"assertion":[{"value":"21 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}